News

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
A man who was the first person in the UK to receive a groundbreaking gene-editing therapy on the NHS, said he felt " ...
CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...
CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.
Scientists at The Jackson Laboratory (JAX) have developed mouse models that survive premature death and enable pre-clinical ...
Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...
We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...
A new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness ...
Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo ...
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with genetic diseases?
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, ...
A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...